Visfatin (NAMPT), elafin, and chemerin are promising candidates for both diagnostic applications and as therapeutic targets in immune-mediated, genetic, environmentally influenced, and inflammatory skin diseases such as psoriasis, primarily due to their dual pro- and anti-inflammatory properties. Here, NAMPT is linked to psoriasis.